Read the order here.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
SAN FRANCISCO — A federal court in California granted partial summary judgment to McKesson in a class action accusing the pharmaceutical distributor of misleading investors by failing to disclose that a generic drug price-fixing scheme was boosting its profits. The class is amended to include those who acquired the company’s stock from Oct. 24, 2013, through Jan. 11, 2016.
Read the order here.
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
